U.S. STOCKS ON THE MOVE-Rollins, Workday, Ford Motor
U.S. STOCKS ON THE MOVE-Tempus AI, SOLV Energy, Replimune
Replimune soars on plans to resubmit melanoma drug application
Brief: Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion With FDA
Replimune gets third chance at US approval for skin cancer drug (updated)
Replimune reaches agreement with US FDA to resubmit melanoma drug application
Brief: Replimune Gets Third Try At FDA Approval After Makary Departure- WSJ
Makary exit may temporarily lift biotech sentiment but FDA leadership vacuum looms
Replimune jumps after US FDA Commissioner Makary resigns
uniQure, Replimune climbs after FDA Commissioner Makary resigns
Replimune, uniQure rise; FDA commissioner Makary plans to resign
FDA commissioner Makary is resigning, sources say (updated)
Replimune, uniQure rise after report FDA chief Makary may be ousted
Replimune surges after report FDA chief Makary may be ousted
Trump plans to fire US FDA chief Makary, sources say (updated)
NASDAQ RESUMED AT 01:19 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:09 PM
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel